Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New supplement combo aims to tame blood sugar in prediabetes and diabetes

NCT ID NCT07195994

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 26 times

Summary

This study tests whether a supplement called AMPK Charge+® can help control blood sugar in adults with prediabetes or type 2 diabetes, either alone or combined with the drug semaglutide. About 90 participants will take the supplement daily, with some also receiving semaglutide injections. Researchers will measure changes in fasting blood sugar, insulin, and HbA1c over 84 days to see which approach works better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES / TYPE 2 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • KGK Science Inc.

    RECRUITING

    London, Ontario, N6B3L1, Canada

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.